Personalis (PSNL) Liabilities and Shareholders Equity (2018 - 2026)
Personalis (PSNL) posted quarterly Liabilities and Shareholders Equity of $325.4 million for Q1 2026, up 19.06% year-over-year from $273.3 million in Q1 2025, and down 2.62% on a QoQ basis from $334.2 million in Q4 2025.
Personalis (PSNL) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Personalis (PSNL) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $325.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 19.06% year-over-year to $325.4 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 19.83% YoY), while the FY2025 annual figure was $334.2 million, up 23.64% from the prior year.
- Liabilities and Shareholders Equity came in at $325.4 million for Q1 2026 at Personalis, down from $334.2 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $380.6 million in Q1 2022, with the low at $185.5 million in Q2 2024.
- Average Liabilities and Shareholders Equity over 5 years is $273.4 million, with a median of $270.3 million recorded in 2024.
- Across the five-year window, Liabilities and Shareholders Equity slumped 30.43% in 2023 and soared 39.96% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $292.7 million in 2022, then dropped by 23.1% to $225.1 million in 2023, then rose by 20.07% to $270.3 million in 2024, then increased by 23.64% to $334.2 million in 2025, then dropped by 2.62% to $325.4 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $325.4 million, $334.2 million, and $242.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 2.61 Bn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 13.07 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Personalis | 1.44 Bn | 1.20 Bn | 281,000.00 | 325.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.40 Mn |
| Dec 31, 2025 | 334.16 Mn |
| Sep 30, 2025 | 242.84 Mn |
| Jun 30, 2025 | 258.68 Mn |
| Mar 31, 2025 | 273.31 Mn |
| Dec 31, 2024 | 270.27 Mn |
| Sep 30, 2024 | 239.89 Mn |
| Jun 30, 2024 | 185.50 Mn |
| Mar 31, 2024 | 195.28 Mn |
| Dec 31, 2023 | 225.10 Mn |
| Sep 30, 2023 | 226.64 Mn |
| Jun 30, 2023 | 249.04 Mn |
| Mar 31, 2023 | 272.18 Mn |
| Dec 31, 2022 | 292.70 Mn |
| Sep 30, 2022 | 317.86 Mn |
| Jun 30, 2022 | 357.98 Mn |
| Mar 31, 2022 | 380.65 Mn |
| Dec 31, 2021 | 396.53 Mn |
| Sep 30, 2021 | 406.69 Mn |
| Jun 30, 2021 | 383.34 Mn |